We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
We are producing guidance and information for industry, healthcare professionals and patients covering the coronavirus (COVID-19) outbreak.
Information for clinicians on diagnosis and notification of Shiga toxin-producing Escherichia coli (STEC) and haemolytic uraemic syndrome (HUS).
How to use an interrupted time series to evaluate your digital health product.
Check the tariff classification for agarose beads chemically modified with 10% by weight of protein A.
From 13 May 2024 we are introducing a change to the procedure for new Marketing Authorisation (MA) applications, where a joint assessment of labels is requested.
Guidance to help you plan and prepare for implementing artificial intelligence (AI).
Information to support your recovery after COVID-19.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Emerging techniques on how to prevent or minimise the environmental impacts of industrial hydrogen production from methane or refinery fuel gas with carbon capture for storage.
The characteristics, diagnosis and management of Candida auris (C. auris).
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Urgent public health message: UKHSA has been notified about an outbreak of food botulism in France involving a small number of British nationals.
Data on the real-world efficacy of the COVID-19 vaccines.
Monitoring significant occupational exposures to HIV, hepatitis B and hepatitis C in healthcare workers, and advising on avoiding injuries.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
The epidemiology, symptoms, diagnosis and management of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2).
The penalties if you are caught taking or dealing drugs - drug classification, fines and prison sentences
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.